Nektar Therapeutics reported $14.62M in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
ALKERMES ALKS:US $ 136.08M 1.9M
Amgen AMGN:US $ 4115M 98M
Baxter International BAX:US $ 2065M 48M
Biogen BIIB:US $ 1254.8M 83M
Bluebird Bio BLUE:US $ 13.5M 4.58M
Bristol Myers Squibb BMY:US $ 2137M 184M
Dr.Reddys Laboratories DRRD:IN IR 50771M 5359M
Eisai 4523:JP Y 89852M 4734M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Esperion Therapeutics ESPR:US $ 23.71M 3.68M
Exelixis EXEL:US $ 24.98M 0.22M
Gilead Sciences GILD:US $ 2988M 8M
GlaxoSmithKline GSK:LN 6330M 114M
Halozyme Therapeutics HALO:US $ 58.55M 0.21M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Karyopharm Therapeutics KPTI:US $ 3.9M 791K
Nektar Therapeutics NKTR:US $ 14.62M 2.19M
Neurocrine Biosciences NBIX:US $ 28.3M 1.8M
Novartis NOVN:VX SF 7111M 114M
Teva Pharmaceutical TEVA:IT 4.36B 44M
YTE INCY:US $ 16.68M 0.02M